Multiple Assemblies exist for SMTL entry 5u7d
PDE2 catalytic domain complexed with inhibitors; X-RAY DIFFRACTION 1.75 Å

	SMTL ID 5u7d.1 Ligands 2-(3,4-dimethoxybenzyl)-7-[(2R,3R)-2-hydroxy-6-phenylhexan-3-yl]-5-methylimidazo[5,1-f][1,2,4]triazin-4(3H)-one; ZINC ION; MAGNESIUM ION Polypeptides cGMP-dependent 3',5'-cyclic phosphodiesterase Oligo-state monomer
	SMTL ID 5u7d.2 Ligands 2-(3,4-dimethoxybenzyl)-7-[(2R,3R)-2-hydroxy-6-phenylhexan-3-yl]-5-methylimidazo[5,1-f][1,2,4]triazin-4(3H)-one; ZINC ION; MAGNESIUM ION Polypeptides cGMP-dependent 3',5'-cyclic phosphodiesterase Oligo-state monomer
	SMTL ID 5u7d.3 Ligands 2-(3,4-dimethoxybenzyl)-7-[(2R,3R)-2-hydroxy-6-phenylhexan-3-yl]-5-methylimidazo[5,1-f][1,2,4]triazin-4(3H)-one; ZINC ION; MAGNESIUM ION Polypeptides cGMP-dependent 3',5'-cyclic phosphodiesterase Oligo-state monomer